Yuva Bioscences
2 known investors
Yuva Biosciences develops and licenses Y100, a cosmetic active ingredient that enhances mitochondrial health to reduce visible signs of aging for use in skincare and haircare products.
Investors · 2
Competitors · 5
by search overlap
Ideaya Biosciences9 shared keywordsIDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers. Its lead candidate, darovasertib, is in late-stage trials for uveal melanoma, with a pipeline spanning PKC inhibition, ADC+DDR combinations, the MTAP pathway, and KAT6/7 inhibition.
VedaBio7 shared keywordsVedaBio develops a molecular detection platform using CRISPR technology that enables rapid, accurate detection of multiple biological targets without the need for amplification. The platform serves research, diagnostics, and industrial applications across multiple markets.
Imvivabio7 shared keywordsA clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases, targeting off-the-shelf and scalable treatments to improve patient access.
Huya Bioscience International6 shared keywordsHUYABIO International develops novel biopharmaceutical products originating in China for global markets, working with biopharmaceutical, academic and commercial partners to advance drug candidates across all therapeutic areas. It maintains a large China-sourced compound portfolio and operates offices across the US, Japan, South Korea, Canada, Ireland and China.
Iovance6 shared keywordsIovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.
Companies competing with Yuva Bioscences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Yuva Bioscences do?
- Yuva Biosciences develops and licenses Y100, a cosmetic active ingredient that enhances mitochondrial health to reduce visible signs of aging for use in skincare and haircare products.
- Who are Yuva Bioscences's investors?
- Yuva Bioscences's investors include TBD Angels, Western Technology Investment.